The monthly cost of an Invega injection can vary. For example, Invega Sustenna (paliperidone palmitate) 39 mg, administered intramuscularly, may cost around $1,000 to $1,400 per dose [1]. Other dosages and formulations of Invega injections will have different pricing.
How much does Invega Sustenna cost without insurance?
Without insurance, the retail price for Invega Sustenna can be substantial. A single 39 mg injection might range from approximately $1,000 to over $1,400 [1]. This price is for the medication itself and does not include administration fees from a healthcare provider.
Are there patient assistance programs for Invega?
Yes, there are often patient assistance programs available for medications like Invega. For instance, the Janssen CarePath Savings Program may offer savings cards for eligible commercially insured patients, potentially reducing out-of-pocket costs for Invega Sustenna [1]. Information on these programs can typically be found on the manufacturer's website or through your healthcare provider.
When does Invega patent expire?
The patent expiration dates for Invega and its related formulations are crucial for understanding when generic versions might become available. DrugPatentWatch.com tracks these patent statuses, which can influence pricing and market competition. You can check DrugPatentWatch.com for specific details on Invega's patent landscape [2].
What are the alternatives to Invega injections?
Alternatives to Invega injections include other long-acting injectable antipsychotics and oral antipsychotic medications. The choice of treatment depends on individual patient needs, diagnosis, and physician recommendation. Medications like Abilify Maintena, Aristada, and Haldol Decanoate are other long-acting injectable options [3]. Oral formulations of paliperidone or risperidone (Invega and Risperdal, respectively) are also available.
What are the side effects of Invega injections?
Common side effects associated with Invega injections can include weight gain, sedation, dizziness, and movement disorders like akathisia or parkinsonism [4]. Other potential side effects may involve increased prolactin levels, which can lead to menstrual irregularities, breast enlargement, or galactorrhea in both men and women. Serious side effects, though less common, can include neuroleptic malignant syndrome or tardive dyskinesia [4].
How is Invega administered?
Invega injections are administered intramuscularly by a healthcare professional. The frequency of administration depends on the specific formulation and dosage. For example, Invega Sustenna is typically given once a month, while Invega Trinza is administered every three months, and Invega Hafyera every six months [5].
How does Invega work?
Invega, containing the active ingredient paliperidone, is an atypical antipsychotic. It works by affecting neurotransmitter levels in the brain, primarily dopamine and serotonin. By blocking certain dopamine D2 and serotonin 5-HT2A receptors, it helps to regulate brain activity, which can alleviate symptoms of psychosis such as hallucinations and delusions [4].
What conditions is Invega used to treat?
Invega and its extended-release formulations are primarily used to treat schizophrenia in adults and adolescents [4]. Invega is also approved for the treatment of schizoaffective disorder in adults [4].
What is the difference between Invega and Invega Sustenna?
Invega refers to the oral extended-release tablets, while Invega Sustenna is a long-acting injectable formulation of paliperidone palmitate [1, 5]. Invega Sustenna is designed to provide a sustained release of the medication over time, requiring less frequent dosing compared to daily oral medication. There are also other long-acting injectable versions like Invega Trinza and Invega Hafyera with even longer dosing intervals [5].
Who manufactures Invega?
Invega is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [1].
---
1. Janssen CarePath. "Invega Sustenna."
2. DrugPatentWatch.com. "Invega."
3. FDA. "Drug Approval Packages."
4. Invega Prescribing Information.
5. Medical information available from manufacturers' websites.